
Vivasvan Vykunta
27 posts

Vivasvan Vykunta
@VivaVykunta
MD-PhD Student @UCSF_MSTP with @MaxKrummel | Previously @MarsonLab @GladstoneInst and Zikherman Lab @UCSF | @PDSoros Fellow '26 | Immuno-engineering and biking




Today, we announced the 2026 Fellows—we hope you will read their incredible stories and learn about their work! Selected from 3,000+ applications, it was the most competitive year in our history. pdsoros.org/meet-the-class…




Excited to share our new review on altered cancer metabolism and implications for next-generation CAR T-cell therapies-- written with @VivaVykunta @GustVandeca @LGKRichardson @WTCNeuroscience @BryanDChoi @MGHNeurosurg Full Paper: authors.elsevier.com/a/1j8rTbEXZb8Dd





Excited to share our latest results published in @SciImmunology unravelling how mast cells control dendritic cell positioning to sustain intestinal IgA production #Cysterlab @ArmeniseHarvard @SanRaffaeleMI @UCSF science.org/doi/10.1126/sc…



Akshara (proudly too cool for Twitter/X/whatever) presenting her honors thesis research from @LabRaleigh at @UCBerkeley. Look for her graduate school application in 2024, folks! @UCSFGradDiv @UCSFCancer @UCSF @NeurosurgUCSF



I’m excited to share our report - out now in @natBME - of a new approach to CRISPR delivery that is poised to transform the way engineered T cell therapies are manufactured. Visit tinyurl.com/CRISPR-PERC for “how to” details. It’s threadin’ time! (1/11) nature.com/articles/s4155…




